Insider · CIK 0001590703

ZSEBO KRISZTINA M

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001590703

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-10	BCDABioCardia, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	24,868
2022-04-14	BCDABioCardia, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31.1K sh	—	—	55,953
2021-06-15	BCDABioCardia, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,434
2021-03-31	BCDABioCardia, Inc.A Award	Director	AAward	+2,736 sh	—	—	2,980
2020-12-31	BCDABioCardia, Inc.A Award	Director	AAward	+244 sh	—	—	244
2015-04-06	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+41.3K sh	$1.12	+$46.3K	44,427
2015-04-06	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+6,629 sh	$8.00	+$53K	51,056
2015-04-06	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−41.3K sh	$18.16	−$750K	9,754
2015-04-06	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,629 sh	$18.44	−$122K	3,125
2015-04-06	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−41.3K sh	—	—	652,346
2015-04-06	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−6,629 sh	—	—	645,717
2015-03-09	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+41.3K sh	$1.12	+$46.3K	44,427
2015-03-09	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+6,629 sh	$8.00	+$53K	51,056
2015-03-09	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−41.3K sh	$24.81	−$1.02M	9,754
2015-03-09	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,629 sh	$24.71	−$164K	3,125
2015-03-09	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−41.3K sh	—	—	700,277
2015-03-09	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−6,629 sh	—	—	693,648
2015-02-09	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+41.3K sh	$1.12	+$46.3K	44,427
2015-02-09	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+6,629 sh	$8.00	+$53K	51,056
2015-02-09	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−41.3K sh	$15.85	−$655K	9,754
2015-02-09	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,629 sh	$15.94	−$106K	3,125
2015-02-09	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−41.3K sh	—	—	748,208
2015-02-09	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−6,629 sh	—	—	741,579
2015-01-06	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+41.3K sh	$1.12	+$46.3K	44,427
2015-01-06	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−41.3K sh	$17.51	−$723K	3,125
2015-01-06	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−41.3K sh	—	—	789,510
2015-01-01	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)A Award	Director, Chief Executive Officer	AAward	−275K sh	—	—	830,812
2014-12-09	Eiger BioPharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+41.3K sh	$1.12	+$46.3K	42,833
2014-12-09	Eiger BioPharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−41.3K sh	$15.00	−$620K	1,531
2014-12-09	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−41.3K sh	—	—	555,812

Recent filings

Accepted (ET)
May 124
ZSEBO KRISZTINA M0001437749-23-014286
SEC(opens sec.gov)
Sep 304
ZSEBO KRISZTINA M0001437749-22-023324
SEC(opens sec.gov)
Jun 154
ZSEBO KRISZTINA M0001437749-21-014883
SEC(opens sec.gov)
Apr 74
ZSEBO KRISZTINA M0001437749-21-008508
SEC(opens sec.gov)
Jan 194
ZSEBO KRISZTINA M0001437749-21-000796
SEC(opens sec.gov)
Apr 74
Celladon Corp0001209191-15-032911
SEC(opens sec.gov)
Mar 94
Celladon Corp0001209191-15-024338
SEC(opens sec.gov)
Feb 104
Celladon Corp0001209191-15-011582
SEC(opens sec.gov)

Companies

Address

12760 HIGH BLUFF DRIVE, STE 240

SAN DIEGO, CA, 92130